The diaTribe team had an outstanding evening in San Francisco for World Diabetes Day on November 14, which included blue hula hooping in Union Square. (For those who...

In exciting news, Vivus announced that it intends to resubmit its weight-loss drug Qnexa to the FDA for review by the end of October. As a reminder, in October 2010, the...

With humor and detail, Gary Scheiner, a certified diabetes educator and author of one of our favorite books about diabetes, Think Like a Pancreas, gives us his...

In late March, the International Diabetes Federation (IDF) released a "position statement" recommending the consideration of bariatric surgery to treat type 2 diabetes...

Earlier this month, the FDA chose not to approve Bristol-Myers Squibb/AstraZeneca’s dapagliflozin, a member of a class of drugs that causes users to excrete excess...

Nine year-old Boaz Alkalay offers a rare glimpse of diabetes through the eyes of a child.

Larry Soler and Dr. James Gavin discuss Partnership for a Healthier America's efforts to fight childhood obesity.

While the rest of America was watching the Super Bowl, we were taking in the countryside in Montpellier, France, at first annual European Diabetes Technology and...

JDRF is offering a $100,000 prize for innovative ideas on how to develop a glucose-responseive insulin Earlier this month, JDRF announced that it would award a $100,000...

Recently, we learned that the Japan-based pharmaceutical company Takeda has submitted its type 2 diabetes therapy alogliptin for approval in the US. The therapy has been...

Kerri Morrone Sparling advocates for unity in the diabetes community.

In October 2010, Biocon, an Indian pharmaceutical company, and Pfizer partnered to develop and market biosimilar insulin analogs (see NewNowNext in diaTribe #26). A...

Earlier in April, Biodel management updated the timeline for the development of its ultra-rapid-acting insulin candidates. As a reminder, in October 2010 the company's...

Recently, we were excited to hear that Sanofi/AgaMatrix have received FDA clearance for the iBGStar , the first blood glucose monitor that connects directly to an Apple...

World Diabetes Day 2007 - Beautiful Landmarks for an Unrecognized Epidemic (B.L.U.E)

We always love attending the ADA Postgrad meeting – an update for doctors and nurses on new practices in diabetes.

While the pharmaceutical industry continues to offer new products, it has been over two years since the FDA has approved a diabetes medication with a completely novel...

April has been quite a busy month for Medtronic with the launch of new CareLink software that is finally Mac-compatible and the introduction of the greatly anticipated...

Kerri Morrone Sparling reflects on the true meaning of ‘need’ in the global diabetes community…

If you’ve been following our coverage of Orexigen’s obesity drug, Contrave, you’re likely aware that it has been through a regulatory rollercoaster over the past few...